| Literature DB >> 32341096 |
Lindsay S Cahill1, Jessie M Cameron2, Julie Winterburn3, Patrick Macos3, Johnathan Hoggarth3, Misko Dzamba4, Michael Brudno4,5, Lauryl M J Nutter6,7, Thomas J Sproule8, Robert W Burgess8, R Mark Henkelman3,9,10, John G Sled3,9,10.
Abstract
An impediment to the development of effective therapies for neurodegenerative disease is that available animal models do not reproduce important clinical features such as adult-onset and stereotypical patterns of progression. Using in vivo magnetic resonance imaging and behavioral testing to study male and female decrepit mice, we found a stereotypical neuroanatomical pattern of progression of the lesion along the limbic system network and an associated memory impairment. Using structural variant analysis, we identified an intronic mutation in a mitochondrial-associated gene (Mrpl3) that is responsible for the decrepit phenotype. While the function of this gene is unknown, embryonic lethality in Mrpl3 knock-out mice suggests it is critical for early development. The observation that a mutation linked to energy metabolism precipitates a pattern of neurodegeneration via cell death across disparate but linked brain regions may explain how stereotyped patterns of neurodegeneration arise in humans or define a not yet identified human disease.SIGNIFICANCE STATEMENT The development of novel therapies for adult-onset neurodegenerative disease has been impeded by the limitations of available animal models in reproducing many of the clinical features. Here, we present a novel spontaneous mutation in a mitochondrial-associated gene in a mouse (termed decrepit) that results in adult-onset neurodegeneration with a stereotypical neuroanatomical pattern of progression and an associated memory impairment. The decrepit mouse model may represent a heretofore undiagnosed human disease and could serve as a new animal model to study neurodegenerative disease.Entities:
Keywords: MRPL3; magnetic resonance imaging; mouse model; neurodegenerative disease
Mesh:
Substances:
Year: 2020 PMID: 32341096 PMCID: PMC7275855 DOI: 10.1523/JNEUROSCI.0013-20.2020
Source DB: PubMed Journal: J Neurosci ISSN: 0270-6474 Impact factor: 6.167